These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 37797813)

  • 1. Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems.
    Aquino-Jarquin G
    Drug Discov Today; 2023 Nov; 28(11):103793. PubMed ID: 37797813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox.
    Koonin EV; Gootenberg JS; Abudayyeh OO
    Biochemistry; 2023 Dec; 62(24):3465-3487. PubMed ID: 37192099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas13 Precision Transcriptome Engineering in Cancer.
    Granados-Riveron JT; Aquino-Jarquin G
    Cancer Res; 2018 Aug; 78(15):4107-4113. PubMed ID: 30021724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini review: genome and transcriptome editing using CRISPR-cas systems for haematological malignancy gene therapy.
    Elliott EK; Haupt LM; Griffiths LR
    Transgenic Res; 2021 Apr; 30(2):129-141. PubMed ID: 33609253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guide RNA engineering enables efficient CRISPR editing with a miniature Syntrophomonas palmitatica Cas12f1 nuclease.
    Wang Y; Wang Y; Pan D; Yu H; Zhang Y; Chen W; Li F; Wu Z; Ji Q
    Cell Rep; 2022 Sep; 40(13):111418. PubMed ID: 36170834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Nucleotide Editing Technologies for Microbial Metabolic Engineering.
    Arazoe T; Kondo A; Nishida K
    Biotechnol J; 2018 Sep; 13(9):e1700596. PubMed ID: 29862665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR based bacterial genome editing and removal of pathogens.
    Jothi R; Karthika C; Kamaladevi A; Satish L; Pandian SK; Gowrishankar S
    Prog Mol Biol Transl Sci; 2021; 179():77-92. PubMed ID: 33785178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review on the Mechanism and Applications of CRISPR/Cas9/Cas12/Cas13/Cas14 Proteins Utilized for Genome Engineering.
    Hillary VE; Ceasar SA
    Mol Biotechnol; 2023 Mar; 65(3):311-325. PubMed ID: 36163606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in stem cells and gene editing: Drug discovery and therapeutics.
    Bayarsaikhan D; Bayarsaikhan G; Lee B
    Prog Mol Biol Transl Sci; 2021; 181():231-269. PubMed ID: 34127195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
    Kavuri NR; Ramasamy M; Qi Y; Mandadi K
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9: A fascinating journey from bacterial immune system to human gene editing.
    Hossain MA
    Prog Mol Biol Transl Sci; 2021; 178():63-83. PubMed ID: 33685600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
    Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
    [No Abstract]   [Full Text] [Related]  

  • 17. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
    Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
    Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR technologies for genome, epigenome and transcriptome editing.
    Villiger L; Joung J; Koblan L; Weissman J; Abudayyeh OO; Gootenberg JS
    Nat Rev Mol Cell Biol; 2024 Jun; 25(6):464-487. PubMed ID: 38308006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the plant genome editing toolbox with recently developed CRISPR-Cas systems.
    Wada N; Osakabe K; Osakabe Y
    Plant Physiol; 2022 Mar; 188(4):1825-1837. PubMed ID: 35099553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.